Dbv Technologies (DBVTF) 52.8000 $DBVTF AAAAI: DBV's

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Dbv Technologies (DBVTF) 52.8000 $DBVTF

AAAAI: DBV's Peanut Data Need Little Buttering Up
EP Vantage - Seeking Alpha - Wed Feb 25, 1:17PM CST
D BV ’s ( OTC BVTF ) limited disclosure of the phase II trial of Viaskin Peanut gave rise to fears that the company was holding back all but its most positive aspects, but in the event it seems that there was little in the full primary...

DBV's Moment Of Truth
EP Vantage - Seeking Alpha - Wed Feb 18, 9:50AM CST
When last year DBV Technologies released limited topline data from a phase II study of its lead asset, Viaskin Peanut , it was enough to allow the French company to sell $133m of stock and complete a secondary offering on Nasdaq. Naturally the...

DBV Technologies: Spoon-Feeding Investors A Buying Opportunity
Don Dion - at Seeking Alpha - Thu Nov 20, 10:16AM CST


U.S. IPO Weekly Recap: With Just 3 IPOs, More Companies Postpone Than Go Public
Renaissance Capital IPO Research - at Seeking Alpha - Sun Oct 26, 12:22PM CDT
Three IPOs raised $164 million, bringing the year's total up to 231 offerings and $74 billion in proceeds. Six deals were expected to raise $550 million to make it the first week in over a month to raise under $1 billion. However, three of those...
ABCW: 34.76 (+0.13), PRTO: 15.47 (+1.21)

House Dust Mite Allergy Therapeutics Pipeline Review 2014 - 6 Companies & 8 Drug Profiles
M2 - Fri Sep 26, 6:03AM CDT
Research and Markets (http://www.researchandmarkets.com/research/2h2mn8/house_dust_mite) has announced the addition of the "House Dust Mite Allergy - Pipeline Review, H2 2014" report to their offering. This report provides comprehensive information on the therapeutic development for House Dust Mite Allergy, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for House Dust Mite Allergy and special features on late-stage and discontinued projects. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Companies Involved in Therapeutics Development - ALK-Abello A/S - DBV Technologies SA - Stallergenes S.A. - Circassia Holdings Ltd. - Anergis SA - Biomay AG Drug Profiles - Actair - allergenic pollen extract of timothy - MK-8237 - House Dust Mite-SPIRE - Subunit Vaccine for Mite Allergy - AllerDM - Viaskin House Dust Mite - PL-103 For more information visit http://www.researchandmarkets.com/research/2h..._dust_mite

Peanut Allergy Pipeline Review, H2 2014 - 9 Companes and 11 Drug Profiles
M2 - Thu Aug 07, 8:21AM CDT
Research and Markets (http://www.researchandmarkets.com/research/7hqg4k/peanut_allergy) has announced the addition of the "Peanut Allergy - Pipeline Review, H2 2014" report to their offering. This report provides comprehensive information on the therapeutic development for Peanut Allergy, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Peanut Allergy and special features on late-stage and discontinued projects. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Companies Involved in Therapeutics Development - BioTech Tools - DBV Technologies SA - HAL Allergy BV - Anergis SA - Immunomic Therapeutics, Inc. - Tunitas Therapeutics, Inc. - Perosphere Inc. - Sementis Ltd - Allergen Research Corporation Drug Profiles - DBV-712 - Allergen for Peanut Allergy - HALMPE-1 - ARA-LAMP-Vax - Recombinant Protein for Peanut Allergy - pnut-ASIT - DN-1017 - Vaccine for Peanut Allergy - Recombinant Vector Vaccine for Peanut Allergy - Vaccine for Peanut Allergy - PER-1080 For more information visit http://www.researchandmarkets.com/research/7h...ut_allergy

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Emdoor’s Rugged Devices Fuel Industry Growth Globally

Updated Category News Views 7

Emdoor Information: A Sturdy Path in Rugged Computing Dive into the heart of the rugged computing terrain, and you may very well run into Emdoor Information—an 18-year-old titan from Shenzhen that’s carved its niche on the backs of rugged tablets, laptops, and handhelds. Publicly listed since 2023 on China’s A-share main board, Emdoor isn't just any player in this...

Continue Reading
NARUTO Card Game Set for June 2027 Global Launch

Updated Category News Views 1

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

Continue Reading
Buying Land in Greeneville: Avoiding Costly Mistakes

Updated Category News Views 15

Diving Headfirst into Raw Land Purchases Buying land isn't like your typical house flip in Greeneville, Tennessee. It's a whole different ballgame out there. You might think you're just purchasing a piece of Mother Earth, but you got to know there's more beneath the surface—quite literally—before you sign anything. You can go from a promising adventure to a...

Continue Reading
AI Revenue Missteps Shake Semiconductor Stocks

Updated Category News Views 11

Nervous Times for Semiconductor Stocks When the semiconductor sector started October like a high-speed train, I thought we might sail through this month without hitting turbulence. But then, in trotted some shaky AI revenue numbers, and bam, the whole sector took a hit off its October highs. The semiconductor stocks, led by giants like Taiwan Semiconductor Manufacturing...

Continue Reading
Arrvel's Thermal Printers: Aiming at E-Com Sellers

Updated Category News Views 12

Arrvel's Thermal Printing Push: An Overview No one would have pegged tiny thermal label printers as game-changers, but here we are. Arrvel's new lineup of thermal printers is shaking up the world for anyone who's ever had to slap on a shipping label or get inventory organized. They're targeting e-commerce folks and small businesses, which sounds like the right move as...

Continue Reading
Southern Company Sparks Swift Power Restoration Post-Isaias

Updated Category News Views 4

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

Continue Reading
Young Visionaries Win Junior Medals at STARMUS VIII

Updated Category News Views 11

Fresh from the Canary Islands' shores, STARMUS VIII has lifted the veil on two young powerhouses shaping tomorrow—Valeria Corrales and Aneeshwar Kunchala. These two have snagged coveted honors, crowning them as champions of their generation. Igniting Passion for Science and the Environment Valeria Corrales isn't just another face in the crowd; she’s the force behind a...

Continue Reading
tm:rw Revolutionizes Retail with Live TikTok Studios

Updated Category News Views 6

tm:rw Takes a Bold Step into Social Commerce Throw out whatever you've thought about traditional brick-and-mortar retail because tm:rw isn't just bending the rules—it's burning the book. Launching nine branded studio spaces at their Times Square flagship, tm:rw is blending live streaming with in-person shopping, all in sync with TikTok Shop. The experience is less about...

Continue Reading
Retail Trading Platforms Report Record Growth in 2026

Updated Category News Views 5

A Boom in Self-Directed Investing Times are changing, folks. More people than ever are taking finance into their own hands, wielding smartphones like fiscal swords in the name of self-directed investment. No middlemen, no fancy office, just straight-up trading from wherever you might be perched. Four major platforms now boast over 41 million funded accounts combined, each...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 3

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading

Top 5 Most Recently Viewed Articles

Insights from APA Corporation's Q3 2024 Financial Update

Updated Category News Views 289

Insights from APA Corporation's Q3 2024 Financial Update HOUSTON -- APA Corporation (Nasdaq: APA) has released key information regarding its third-quarter 2024 financial and operational results. This supplemental information serves as a guide for investors, analysts, and stakeholders to help them form their own estimates regarding the company's performance. Understanding...

Continue Reading
MeiraGTx and Hologen AI's Partnership to Revolutionize Parkinson's Treatment

Updated Category News Views 197

MeiraGTx and Hologen AI Team Up for Parkinson's Disease Development In a major step forward in medical science, MeiraGTx Holdings plc (NASDAQ: MGTX) has formed a strategic alliance with Hologen Limited, an innovator in generative AI technology aimed at enhancing clinical medicine and pharmaceutical advancements. This partnership marks a pivotal moment in the effort to...

Continue Reading
Ferguson Enterprises Secures $750 Million Financing for Growth

Updated Category News Views 113

Ferguson Enterprises Inc. took a bold step back in early 2024, pricing a public offering of senior unsecured notes amounting to $750 million. Traders were already buzzing about what this meant for Ferguson's position in the distribution sector, especially considering their commitment to expand operations and maintain market leadership. Unpacking the Offering: What’s in...

Continue Reading
Power Metallic Mines Celebrates Successful Summer Drilling Results

Updated Category News Views 160

Exciting Drilling Results from Power Metallic Mines Power Metallic Mines Inc. (TSXV: PNPN) (OTCBB: PNPNF) has announced remarkable results from its summer drilling program. This initiative has generated significant high-grade assay findings, notably 22.66 meters averaging 4.57% CuEq in Hole 020, including a substantial 6.05 meters with a remarkable 9.70% CuEq....

Continue Reading
Fermi (FRMI) Faces Class Action: Key Date and What It Means

Updated Category News Views 271

What’s the Deal with Fermi (FRMI)? Listen up, folks. If you've bought into Fermi (NASDAQ: FRMI) at any point between October and December 2025, or grabbed shares during their October IPO, you might be sitting on something nasty. There’s a class action lawsuit brewing, and the deadline to join the fight is March 6, 2026. It’s huge, absolutely huge—time’s...

Continue Reading